NASDAQ · Drug Manufacturers - Specialty & Generic

CRON (CRON) Stock

$2.83 -2.08% NASDAQ: CRON Healthcare

Valuation

MetricValue
Price$2.83
Market Cap$1.06B
P/E Ratio-131.00
P/B Ratio0.92
P/S Ratio6.18
EPS (TTM)$0.00
52-Week High$3.43
52-Week Low$1.84
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE0.45%
ROA-0.78%
ROCE-0.26%
Gross Margin42.19%
Operating Margin-7.77%
Net Margin-1.29%
Debt/Equity0.00
Current Ratio19.67

Annual Financials (USD)

Metric20212022202320242025
Revenue$65.0M$87.0M$87.0M$118.0M$193.0M
Operating Profit$-292.0M$-111.0M$-85.0M$-77.0M$-3.0M
Net Profit$-396.0M$-169.0M$-74.0M$41.0M$-9.0M
EPS$-1.07$-0.45$-0.19$0.11$-0.02
Op Margin-452.2%-128.4%-97.2%-65.1%-1.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.4B$1.2B$1.1B$1.2B$1.2B
Total Liabilities$63.0M$72.0M$44.0M$55.0M$54.0M
Cash$887.0M$765.0M$669.0M$859.0M$792.0M
Borrowings$10.0M$4.0M$3.0M$2.0M$2.0M

Latest News

Cronos Group Inc. to Hold 2026 Second Quarter Earnings Conference Call on August 6, 2026 GlobeNewswire · Jul 16, 2026 TLRY Plans Strategic Medical Cannabis Expansion: Time to Buy or Sell? Zacks · Jul 2, 2026 Cronos Announces Appointment of ATB Cormark as its Broker for Share Repurchases in Canada GlobeNewswire · Jun 30, 2026 CRON Strengthens Global Footprint: Is the Cannabis Stock Worth Buying? Zacks · Jun 24, 2026 Cronos Group Inc. Announces Results of 2026 Annual Meeting of Shareholders GlobeNewswire · Jun 22, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-154.0M$-89.0M$-43.0M$19.0M$26.0M
Investing Cash Flow$-41.0M$-7.0M$-63.0M$162.0M$-110.0M
Financing Cash Flow$-13.0M$-3.0M$-1.0M$-1.0M$-20.0M
Net Cash Flow$-191.0M$-122.0M$-95.0M$190.0M$-68.0M
Free Cash Flow$-166.0M$-94.0M$-46.0M$6.0M$0

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA-115510.63
FCF Yield2.69%
Quick Ratio20.73
Interest Coverage—
Return 1Y31.10%
Return 3Y48.11%
Return 5Y-63.53%

Ownership

Insiders Held48.55%
Institutions Held15.64%
Institutions Float Held30.39%
Institutional HolderSharesReport Date
Chescapmanager LLC7,942,7372026-03-31
Shaw D.E. & Co., Inc.7,618,2272026-03-31
Pillsbury Lake Capital LLC4,223,0042026-03-31
Tidal Investments LLC4,026,8922026-03-31
Dimensional Fund Advisors LP2,679,0512026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About CRON

CRON is led by CEO Michael Ryan Gorenstein, employs 459 people, headquartered in CA, publicly traded since 2018.

CRON stock trades at $2.83 with a market capitalization of $1.06B. The stock is valued at a price-to-earnings (P/E) ratio of -131.00, price-to-book of 0.92, price-to-sales of 6.18. Over the past 52 weeks the stock has ranged between $1.84 and $3.43, and currently trades 17.5% below its 52-week high.

On profitability, CRON generates a return on equity (ROE) of 0.45%, return on capital employed of -0.26%, an operating margin of -7.77%, a net profit margin of -1.29%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides